As interest in diabetes and weight-loss medications such as Ozempic, Wegovy, and Zepbound surged in recent years, supplement manufacturers responded by launching a number of GLP-1-branded products including pills, powders, drops, and patches
Injury documentation : Detailed documentation of the injuries or conditions allegedly caused by Ozempic, such as pancreatitis, thyroid tumors, kidney damage, or severe gastrointestinal issues
Moreover, the analysis indicated a non-significant trend towards a reduction in cardiovascular death or non-fatal myocardial infarction
No official NICE or MHRA guidance exists for this combination, and there is insufficient clinical trial data on safety
This isnt a decision to make lightly